Evidence map›Paper›PMID 20509914›Full record

ArticleBMC gastroenterology2010

Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.

Chantal A Rivera, LaTausha Gaskin, Monique Allman, Jia Pang, Kristen Brady, Patrick Adegboyega, Kevin Pruitt

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 73 citations in OpenAlex.

  1. Gut microbiota in MAFLD: therapeutic and diagnostic implications.Therapeutic advances in endocrinology and metabolism · 2024
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. The role of the microbiome in NAFLD and NASH.EMBO molecular medicine · 2019
    Review
  7. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.International journal of molecular sciences · 2019
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Genetic polymorphism inWorld journal of gastroenterology · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH.Canadian journal of gastroenterology & hepatology · 2016
    Review
  20. Animal Models Correlating Immune Cells for the Development of NAFLD/NASH.Journal of clinical and experimental hepatology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chantal A RiveraDepartment of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA. crive1@lsuhsc.edu
LaTausha Gaskin
Monique Allman
Jia Pang
Kristen Brady
Patrick Adegboyega
Kevin Pruitt
Louisiana State University Health Sciences Center Shreveport · US

Funding

VASCULAR REACTIVITY FOLLOWING ISCHEMIA-REPERFUSIONP01DK043785 · NIDDK · LOUISIANA STATE UNIV HSC SHREVEPORT · PI GRANGER, D. NEIL · 1991 to 2011
$17.0M
Role of adipocytes in local and systemic inflammationK01HL084723 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI RIVERA, CHANTAL A · 2006 to 2010
$662k
NHLBI NIH HHS 1K01HL084723-01NIDDK NIH HHS 3P01DK43785-13S1
6 · The paper itself

Abstract

backgroundPreviously we reported that mice deficient in toll-like receptor 4 (TLR-4) signalling were protected from diet-induced non-alcoholic steatohepatitis (NASH). Another member of the toll-like receptor family, TLR-2, has been shown to play a role in lipid trafficking via uptake of diacylated lipoproteins. However, a role for TLR-2 in NASH has not been elucidated. The objectives of the current study were to examine the influence of dietary fat quality and TLR-2 on NASH pathogenesis.

methodsSteatohepatitis was induced in male Db, C57BL/6 and TLR-2(-/-) mice by feeding an L-amino acid-defined diet that was deficient in methionine and choline (MCDD). Mice fed the base diet supplemented with methionine and choline (control diet; CD) were used as controls. To determine the role of fat quality, MCDD was enriched with polyunsaturated corn oil (PUFA) or coconut oil that is comprised mostly of saturated fat (SAFA); the total amount of each fat was 112.9 g/kg of diet. After 8 weeks of feeding CD or MCDD, hepatic steatosis, inflammation and necrosis were evaluated in histological sections. Total RNA was extracted from frozen liver samples and mRNA expression of TNFalpha, collagen alpha1, IL-10, peroxisome proliferator-activated receptor-gamma (PPAR-gamma), TLR-4, and CD14, was analyzed via real-time PCR. Protein levels of TLR-2 were analyzed by western blot.

resultsPanlobular macrovessicular steatosis and diffuse leukocyte infiltration were noted in PUFA-fed Db mice. Histological scores demonstrated significantly less steatosis, inflammation and necrosis in SAFA-fed mice of all mouse strains. However, compared to wild type mice, hepatocellular damage was notably more severe in TLR-2(-/-) mice. Consistent with histological findings, mRNA expression of TNFalpha was elevated by approximately 3-fold in TLR-2(-/-) mice; PPAR-gamma expression was blunted in this strain compared to wild type. Expression of the matrix protein collagen alphaI was also significantly higher in TLR-2(-/-) mice, indicating a pro-fibrogenic state. Sensitivity to steatohepatitis due to dietary fat or TLR-2 deficiency correlated significantly with alterations in the expression of TLR-4 as well as the co-receptor CD-14.

conclusionsOur findings suggest that dietary saturated fat plays a protective role against MCDD-induced steatohepatitis, whereas TLR-2 deficiency exacerbated NASH. The mechanism underlying the response to dietary fat and TLR-2 likely involves altered signalling via the TLR-4 pathway.

Indexed as

Choline DeficiencyAnimalsCollagen Type IDietary FatsDietary Fats, UnsaturatedDisease Models, AnimalFatty LiverMaleMethionineMiceMice, Inbred C57BLMice, KnockoutPPAR gammaSignal TransductionToll-Like Receptor 2Toll-Like Receptor 4Collagen Type IDietary FatsDietary Fats, UnsaturatedMethioninePPAR gammaTlr2 protein, mouseTlr4 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID20509914
PMCPMC2891617
OpenAlexW1999005524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.